EXAS vs REVG · rev $2.76B vs P/E 34, rev $2.38B
EXACT Sciences Corporation (EXAS) versus Rev Group Inc (REVG) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Rev Group Inc (REVG) is a farm & heavy construction machinery company listed on NYSE.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported REVG revenue for 2024-10-31 was $2.38B. Net income was $257.6M. Revenue was down 9.8% from 2023-10-31 to 2024-10-31. REVG currently screens at market cap $3.12B and trailing P/E 33.8.
EXAS currently screens at market cap $20.03B. REVG currently screens at market cap $3.12B and trailing P/E 33.8.
Not investment advice. Open the EXAS and REVG stock pages for the full models.
Not investment advice.